Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at afatinib for non small cell lung cancer (ABLE)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a drug called afatinib before surgery for people with early stage non small cell lung cancer.

Recruitment start: 23 July 2014

Recruitment end: 30 September 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Clive Mulatero

Supported by

Boehringer Ingelheim

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

University of Leeds

Last reviewed: 26 Oct 2016

CRUK internal database number: 11075

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.